Brigid Unim
Sapienza University of Rome
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Brigid Unim.
Human Vaccines & Immunotherapeutics | 2013
Brigid Unim; Rosella Saulle; Sara Boccalini; Cristina Taddei; Vega Ceccherini; Antonio Boccia; Paolo Bonanni; Giuseppe La Torre
Introduction: The aim of the present study is to review the economic burden of varicella disease and the benefit of universal varicella vaccination in different settings pending its implementation in all Italian regions. Materials and Methods: Research was conducted using PubMed, Scopus and ISI databases. Score quality and data extraction were performed for all included studies. Results: Twenty-three articles met the criteria: 15 cost-effectiveness, 8 cost-benefit and one cost-utility analysis. Varicella vaccination could save the society from €637,762 (infant strategy) to 53 million annually (combined infant and adolescent strategy). The median and the mean quality scores resulted in 91.8% and 85.4% respectively; 11 studies were considered of high quality and 12 of low quality. Discussion: The studies are favorable to the introduction of universal varicella vaccination in Italy, being cost saving and having a positive impact on morbidity. The quality score of the studies varied greatly: recent analyses were of comparable quality to older studies.
Vaccine | 2014
Antonietta Spadea; Brigid Unim; Vittoria Colamesta; A. Meneghini; Am D’Amici; B. Giudiceandrea; G. La Torre
INTRODUCTION Influenza illness is an important public health problem and annual vaccination is globally recommended for high risk populations. OBJECTIVE The aim was to evaluate and compare the effectiveness of influenza vaccines in reducing hospitalizations for influenza or pneumonia during two influenza seasons in the elderly. METHODS A case-control study was performed, using administrative database of the Local Health Unit Roma-A (LHU RM-A). The included subjects were at least 65 years old and residing in one of the four districts of the LHU. The cases were hospitalized for influenza or pneumonia during influenza season in the years 2010-2011 and 2011-2012. The controls were hospitalized in the same period, but not for influenza or pneumonia. The subjects were immunized with the trivalent inactivated influenza vaccine (TIV) in the first influenza season (2010-2011) and with the adjuvanted influenza vaccine MF59 (ATIV) in the second season (2011-2012). RESULTS A total of 269 cases and 1247 controls were included for the 2010-2011 influenza season, and 365 cases and 1227 controls were selected for the 2011-2012 season. Up to 63.6% cases and 53.5% controls in the 2010-2011 season and 78.6% of cases and 64.1% of controls in the 2011-2012 season have not been vaccinated. Female gender and high educational level were protective factors for hospitalization. Subjects over 75 years were at high risk of hospitalization compared to 65-74 years olds. Influenza vaccination reduced significantly hospitalization in both seasons. In subjects with 65-74 years TIV was more effective than ATIV; vice versa for those over 75 years old. DISCUSSION AND CONCLUSION TIV and ATIV reduce hospitalization for influenza or pneumonia with a variable degree of protection in different age groups. In particular, ATIV is more effective in individuals over 75 years old.
BioMed Research International | 2014
Giuseppe La Torre; Rosella Saulle; Brigid Unim; Italo F. Angelillo; Vincenzo Baldo; Margherita Bergomi; Paolo Cacciari; Silvana Castaldi; Giuseppe Del Corno; Francesco Di Stanislao; Augusto Panà; Pasquale Gregorio; Orazio Claudio Grillo; Paolo Grossi; Francesco La Rosa; Nicola Nante; Maria Pavia; Gabriele Pelissero; Michele Quarto; Walter Ricciardi; Gabriele Romano; Schioppa F; Roberto Fallico; Roberta Siliquini; Maria Triassi; Francesco Vitale; Antonio Boccia
Background. Healthcare professionals have an important role to play both as advisers—influencing smoking cessation—and as role models. However, many of them continue to smoke. The aims of this study were to examine smoking prevalence, knowledge, attitudes, and behaviours among four cohorts physicians specializing in public health, according to the Global Health Profession Students Survey (GHPSS) approach. Materials and Methods. A multicentre cross-sectional study was carried out in 24 Italian schools of public health. The survey was conducted between January and April 2012 and it was carried out a census of students in the selected schools for each years of course (from first to fourth year of attendance), therefore among four cohorts of physicians specializing in Public Health (for a total of n. 459 medical doctors). The GHPSS questionnaires were self-administered via a special website which is created ad hoc for the survey. Logistic regression model was used to identify possible associations with tobacco smoking status. Hosmer-Lemeshow test was performed. The level of significance was P ≤ 0.05. Results. A total of 388 answered the questionnaire on the website (85%), of which 81 (20.9%) declared to be smokers, 309 (79.6%) considered health professionals as behavioural models for patients, and 375 (96.6%) affirmed that health professionals have a role in giving advice or information about smoking cessation. Although 388 (89.7%) heard about smoking related issues during undergraduate courses, only 17% received specific smoking cessation training during specialization. Conclusions. The present study highlights the importance of focusing attention on smoking cessation training, given the high prevalence of smokers among physicians specializing in public health, their key role both as advisers and behavioural models, and the limited tobacco training offered in public health schools.
Infection Control and Hospital Epidemiology | 2016
Alice Mannocci; Gabriella De Carli; Virginia Di Bari; Rosella Saulle; Brigid Unim; Nicola Nicolotti; Lorenzo Carbonari; Vincenzo Puro; Giuseppe La Torre
OBJECTIVE To provide an overview of the economic aspects of needlestick and sharps injury (NSI) management among healthcare personnel (HCP) within a Health Technology Assessment project to evaluate the impact of safety-engineered devices on health care METHODS A systematic review of economic analyses related to NSIs was performed in accordance with the PRISMA statement and by searching PubMed and Scopus databases (January 1997–February 2015). Mean costs were stratified by study approach (modeling or data driven) and type of cost (direct or indirect). Costs were evaluated using the CDC operative definition and converted to 2015 International US dollars (Int
Epidemiology, biostatistics, and public health | 2013
Stefano Vando; Brigid Unim; Salvatore A. Cassarino; Johnny Padulo; Daniele Masala
). RESULTS A total of 14 studies were retrieved: 8 data-driven studies and 6 modeling studies. Among them, 11 studies provided direct and indirect costs and 3 studies provided only direct costs. The median of the means for aggregate (direct + indirect) costs was Int
Human Vaccines & Immunotherapeutics | 2017
Giuseppe La Torre; Rosella Saulle; Brigid Unim; Angela Meggiolaro; Angelo Barbato; Alice Mannocci; Antonietta Spadea
747 (range, Int
The Scientific World Journal | 2015
Brigid Unim; Maria Assunta Veneziano; Antonio Boccia; Walter Ricciardi; Giuseppe La Torre
199–Int
Public Health | 2015
Guglielmo Giraldi; Brigid Unim; Daniele Masala; Silvia Miccoli; G. La Torre
1,691). The medians of the means for disaggregated costs were Int
Journal of Public Health | 2014
Alice Mannocci; Rosella Saulle; Vittoria Colamesta; Silvia D'Aguanno; Guglielmo Giraldi; Emanuele Maffongelli; Angela Meggiolaro; Leda Semyonov; Brigid Unim; Giuseppe La Torre
425 (range, Int
Public Health | 2016
Brigid Unim; C De Vito; Azzurra Massimi; Elvira D'Andrea; Annalisa Rosso; Paolo Villari; Carolina Marzuillo
48–Int